Abstract
Breast cancers are among the types of neoplasm with the highest sensitivity to currently available chemotherapy, at least in terms of rates of response and regression. Unfortunately, this does not mean that chemotherapy is completely able to eradicate detectable or occult metastases of these cancers and therefore permanently cure a significant number of them. This point still remains to be demonstrated, as can easily be understood if we look at the list of theoretical and practical limitations encountered in antineoplastic chemotherapy.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Curt, G.A., Clendeninn, N.J. and Chabner B.A.: Drug resistance in cancer. Cancer Treat.Rep., 68: 87–99, 1984.
Legha, S.S., Buzdar, A.U. and Smith, T.L. et al., Complete remissions in metastatic breast cancer treated with combination drug therapy. Ann. Intern. Med, 91: 847–852, 1979.
Cummings, F.J., Gelman, R. and Horton, J. Comparison of CAF versus CMFP in metastatic breast cancer. Analysis of prognostic factors. J. Clin. Oncol. 3 :932–940, 1985.
Israel, L., Breau, J.L. and Aguilera, J.: High-dose cyclophosphamide and high dose 5 fluorouracil. A new first-line regimen for advanced breast cancer. Cancer, 53: 1655–1659, 1984.
Breau, J.L., Israel, L., Morère, J.F. and Aguilera, J.: Second-line treatment of advanced breast cancer resistant to cyclophosphamide, methotrexate, 5 fluorouracil (CMF) with bleomycin, adriamycin and cisplatinum (BAP) combination chemotherapy. Proceedings of ASCO, 1986, (in press).
Mouridsen, H.T. and Palshof, T.: Adjuvant systemic therapy in breast cancer; a review. Eur. J. Cancer Clin. Oncol.19: 1753–1770, 1983.
Consensus Conference. Adjuvant chemotherapy for breast cancer. JAMA, 254: 3461–3463, 1985.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Martinus Nijhoff Publishers, Dordrecht
About this chapter
Cite this chapter
Israel, L. (1986). Chemotherapy for Breast Cancers. In: Hollmann, K.H., Verley, J.M. (eds) New Frontiers in Mammary Pathology 1986. Developments in Oncology, vol 49. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-3297-5_28
Download citation
DOI: https://doi.org/10.1007/978-94-009-3297-5_28
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-7980-8
Online ISBN: 978-94-009-3297-5
eBook Packages: Springer Book Archive